Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Xigduo XR (dapagliflozin and metformin HCl extended release) is indicated as substitution therapy for treatment of type 2 diabetes mellitus in adjunct to diet and exercise to improve glycemic control in adults patients already controlled with dapagliflozin and metformin XR given concurrently at the same dose level. (See Pharmacology: Pharmacodynamics: Clinical Trial Information under Actions and Precautions for available data on combination therapy).

Xigduo XR Indications/Uses

Manufacturer:

AstraZeneca